Skip to content
Triangle logo TriangleGet started
← All settings

DISEASE & TREATMENT SETTING

Childhood Medulloblastoma

Source-derived catalogue. This is not a treatment recommendation or a personalised trial match.

Exact scope

Medulloblastoma in children and adolescents

Source population
pediatric
Disease extent
Not part of this definition
Treatment line
Not part of this definition
Stage
Not part of this definition
Resectability
Not part of this definition
Biomarkers, prior therapy and derivation
molecular
    prior therapy
      derivation status
      unresolved
      derivation note
      Derived from NCI topic(s): Childhood Medulloblastoma and Other Central Nervous System Embryonal Tumors. Strongest NCIt resolution: ambiguous. Entity-level scope; stage, biomarker and treatment line are not yet part of this definition.
      source wording
      Source null
      1 more-specific settings
      recurrent Childhood Medulloblastoma →

      Study evidence for this setting

      5 linked studies · Applicability is a draft source assessment, not a determination of your eligibility.

      NCT01869725 · Registry condition search · Scope: narrower

      Comparative Study of Sensitivity of Ga-DOTATOC PET vs Octreoscan SPECT + CT

      3 outcome links · 1 safety-group records · 0 quality-of-life measures

      →

      NCT01987596 · Registry condition search · Scope: narrower

      Study of Fixed vs. Flexible Filgrastim to Accelerate Bone Marrow Recovery After Chemotherapy in Children With Cancer

      4 outcome links · 2 safety-group records · 0 quality-of-life measures

      →

      NCT02255461 · Source cited / selected · Scope: narrower

      Palbociclib Isethionate in Treating Younger Patients With Recurrent, Progressive, or Refractory Central Nervous System Tumors

      6 outcome links · 5 safety-group records · 0 quality-of-life measures

      →

      NCT02624388 · Registry condition search · Scope: narrower

      Study of Genistein in Pediatric Oncology Patients (UVA-Gen001)

      6 outcome links · 4 safety-group records · 1 quality-of-life measures

      →

      NCT03210714 · Registry condition search · Scope: narrower

      Erdafitinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With FGFR Mutations (A Pediatric MATCH Treatment

      5 outcome links · 1 safety-group records · 0 quality-of-life measures

      →
      Source relationships and population-mapping limitations
      bindings
      1. release id
        clinical-indications-draft-1
        disease state id
        ds-medulloblastoma-pediatric
        binding id
        ncit-C3222
        source collection
        ncit-concept
        source key
        C3222
        source excerpt
        Source null
        match status
        ambiguous
        match note
        Resolution status: ambiguous.
        recorded at
        2026-09-10T00:00:00Z
      2. release id
        clinical-indications-draft-1
        disease state id
        ds-medulloblastoma-pediatric
        binding id
        ncit-C3997
        source collection
        ncit-concept
        source key
        C3997
        source excerpt
        Source null
        match status
        ambiguous
        match note
        Resolution status: ambiguous.
        recorded at
        2026-09-10T00:00:00Z
      3. release id
        clinical-indications-draft-1
        disease state id
        ds-medulloblastoma-pediatric
        binding id
        ncit-C4011
        source collection
        ncit-concept
        source key
        C4011
        source excerpt
        Source null
        match status
        ambiguous
        match note
        Resolution status: ambiguous.
        recorded at
        2026-09-10T00:00:00Z
      mappings

        Download this complete draft source relationship record →

        Preserved source evidence · Not medical advice